Alzheimer Disease and Metabolism: Role of Cholesterol and Membrane Fluidity

Ortiz, Genaro G.; Pacheco-Moisés, Fermín Paul; Flores-Alvarado, Luis Javier; Macías-Islas, Miguel Ángel; Velázquez-Brizuela, Irma E.; Anguiano, Ana Cristina Ramírez; Torres‐Sánchez, Erandis D.; Morales-Sánchez, Eddic W.; Cruz-Ramos, José Alfonso; Ortiz-Velázquez, Genaro E; Cortés-Enríquez, Fernando

doi:10.5772/54091

Understanding Alzheimer's Disease 2013

DOI: 10.5772/54091

|View full text |Cite

Alzheimer Disease and Metabolism: Role of Cholesterol and Membrane Fluidity

Genaro G. Ortiz¹,

Fermín Paul Pacheco-Moisés²,

Luis Javier Flores-Alvarado³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 125 publications

(126 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Role of Oxysterols in the Activation of the NLRP3 Inflammasome as a Potential Pharmacological Approach in Alzheimer's Disease

Martins

Ferreira

Palotás³

et al. 2023

View full text Add to dashboard Cite

Alzheimer's disease (AD), the most prevalent form of dementia, is a complex clinical condition with multifactorial origin posing a major burden to health care systems across the world. Even though the pathophysiological mechanisms underlying the disease are still unclear, both central and peripheral inflammation have been implicated in the process. Piling evidence shows that the nucleotide-binding domain, leucine-rich repeat and pyrin domain containing protein 3 (NLRP3) inflammasome is activated in AD. As dyslipidemia is a risk factor for dementia, and cholesterol can also activate the inflammasome, a possible link between lipid levels and the NLRP3 inflammasome has been proposed in Alzheimer's. It is also speculated that not only cholesterol but also its metabolites, the oxysterols, may be involved in AD pathology. In this context, mounting data suggest that NLRP3 inflammasome activity can be modulated by different peripheral nuclear receptors, including liver-X receptors, which present oxysterols as endogenous ligands. In light of this, the current review explores whether the activation of NLRP3 by nuclear receptors, mediated by oxysterols, may also be involved in AD and could serve as a potential pharmacological avenue in dementia.

show abstract

Role of Oxysterols in the Activation of the NLRP3 Inflammasome as a Potential Pharmacological Approach in Alzheimer's Disease

Martins

Ferreira

Palotás³

et al. 2023

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Alzheimer Disease and Metabolism: Role of Cholesterol and Membrane Fluidity

Cited by 1 publication

References 125 publications

Role of Oxysterols in the Activation of the NLRP3 Inflammasome as a Potential Pharmacological Approach in Alzheimer's Disease

Role of Oxysterols in the Activation of the NLRP3 Inflammasome as a Potential Pharmacological Approach in Alzheimer's Disease

Contact Info

Product

Resources

About